Spero Therapeutics participates in Guggenheim Healthcare Innovation Conference

SPRO•2026-11-02

Spero Therapeutics will attend the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on Nov. 10, 2026, and the Jefferies Global Healthcare Conference in London on Nov. 18-19.

1. Conference appearances

Spero Therapeutics CEO Esther Rajavelu will participate in a fireside chat at 10:30 a.m. ET at the Guggenheim conference, where company leadership will also be available for investor meetings. Management will meet investors at the Jefferies Global Healthcare Conference in London on Nov. 18-19.

Spero Therapeutics participates in Guggenheim Healthcare Innovation Conference

1. Conference appearances

Related News

People Incorporated forecasts FY2026 adjusted EBITDA of $263 million to $283 million

Wayfair President of Commercial & Operations Jon Blotner sells $60,000 in common shares

Diversified Energy unit enters fourth amendment to revolving credit agreement

Resolution Capital says high costs undermine new housing supply economics

Mid Penn Bank names Robert Curley president of eastern division